Patient-reported outcomes in studies comparing the early integration of palliative care with standard oncology care in patients with advanced cancer
Boldface type indicates significant differences found between intervention and control groups.
RCT indicates randomize controlled trial; PC, palliative care; NSCLC, non-small cell lung cancer; FACT-L, Functional Assessment of Cancer Therapy-Lung, LCS, Lung Cancer Subscale; TOI, Trial Outcome Index; GI, gastrointestinal; GU, genitourinary; FACIT-Sp, Functional Assessment of Chronic Illness Therapy-Spiritual Well Being; QUAL-E, Quality of Life at the End of Life; CES-D, Center for Epidemiologic Studies-Depression; ESAS, Edmonton Symptom Assessment System; CARES-MIS, Cancer Rehabilitation Evaluation System Medical Interaction Subscale; HADS-D, Hospital Anxiety and Depression Scale Depression Subscale; HADS-A, Hospital Anxiety and Depression Scale Anxiety Subscale; PHQ-9, Patient Health Questionnaire 9; EORTC QLQ-C30, European Organization for Research and Treatment of Cancer-Quality of Life Questionnaire- Core 30; FACIT-Pal, Functional Assessment of Chronic Illness Therapy-Palliative Care; CQOL-C, Caregiver QOL Scale-Cancer (CQOL-C); MBCB-OB, Montgomery-Borgatta Caregiver Burden Scale, Overall Burden subscale; MBCB-SB, Montgomery-Borgatta Caregiver Burden, Stress Burden subscale; and MBCB-DB; Montgomery-Borgatta Caregiver Burden, Depression Burden subscale.
